Next Article in Journal
Association Between Dietary Patterns and Lifestyle Habits with Vascular Inflammatory Responses in Individuals with Hypertension Living in PM2.5-Polluted Areas: A Cross-Sectional Pilot Study in Chiang Mai Province, Thailand
Previous Article in Journal
Ten-Year Trends in Hepatocellular Carcinoma Mortality: Examining the Interaction Between Fibrosis Score and Patient Age
Previous Article in Special Issue
Hepatocellular Carcinoma: A Comprehensive Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Amin et al. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025, 13, 207

1
Department of Internal Medicine, Charleston Area Medical Center, Charleston, WV 25304, USA
2
Department of Pathology, Charleston Area Medical Center, Charleston, WV 25304, USA
3
Department of Gastroenterology and Hepatology, Charleston Area Medical Center, Charleston, WV 25304, USA
*
Author to whom correspondence should be addressed.
Diseases 2025, 13(8), 257; https://doi.org/10.3390/diseases13080257
Submission received: 7 August 2025 / Accepted: 7 August 2025 / Published: 13 August 2025
(This article belongs to the Special Issue Viral Hepatitis: Diagnosis, Treatment and Management)

1. Table Legend

In the original publication [1], there was a mistake in the legend for Table 2. Table 2 did not include the data source in the table footer. The correct legend appears below.
Major features include enhancing “capsule”, non-peripheral “washout”, and threshold growth. * If enhancing “capsule” (LR-4), non-peripheral “washout”, or threshold growth (LR-5). Table 2 was created using data from the AASLD 2023 guidelines [63].

2. Error in Figures 2–4

In the original publication, there was a mistake in Figures 2–4 as published. Figures 2–4 lacked scale bars and corresponding descriptions in their legends. The corrected versions of Figure 2, Figure 3 and Figure 4 appear below.

3. Missing Institutional Review Board and Informed Consent Statement

In the original publication, the Institutional Review Board and Informed Consent Statement were not included.
Institutional Review Board Statement: The histological images (Figures 2–4) were obtained from de-identified human tissue samples. As no identifiable patient information is included, this study was exempt from IRB review in accordance with institutional guidelines.
Informed Consent Statement: Histologic images were used in accordance with institutional regulations. Per institutional policy, informed consent was not required for the use of de-identified pathology images.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Amin, N.; Anwar, J.; Sulaiman, A.; Naumova, N.N.; Anwar, N. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025, 13, 207. [Google Scholar] [CrossRef] [PubMed]
Figure 2. Cytological preparation of lesional material; the lesional material shows atypical sheets of cells in both diff-quick (bright blue) and pap stain (pink cytoplasm). Scale bar: 20 µm.
Figure 2. Cytological preparation of lesional material; the lesional material shows atypical sheets of cells in both diff-quick (bright blue) and pap stain (pink cytoplasm). Scale bar: 20 µm.
Diseases 13 00257 g002
Figure 3. H&E staining of the specimen with atypical cells with some areas of clear/vacuolated cytoplasm. The arrow highlights endothelial wrapping, a feature suggestive of hepatocellular carcinoma. Scale bar: 200 µm.
Figure 3. H&E staining of the specimen with atypical cells with some areas of clear/vacuolated cytoplasm. The arrow highlights endothelial wrapping, a feature suggestive of hepatocellular carcinoma. Scale bar: 200 µm.
Diseases 13 00257 g003
Figure 4. IHC staining to confirm metastasis; both hepatocyte markers were positive, therefore supporting the diagnosis of a metastatic hepatocellular carcinoma. Scale bar: 50 µm.
Figure 4. IHC staining to confirm metastasis; both hepatocyte markers were positive, therefore supporting the diagnosis of a metastatic hepatocellular carcinoma. Scale bar: 50 µm.
Diseases 13 00257 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Amin, N.; Anwar, J.; Sulaiman, A.; Naumova, N.N.; Anwar, N. Correction: Amin et al. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025, 13, 207. Diseases 2025, 13, 257. https://doi.org/10.3390/diseases13080257

AMA Style

Amin N, Anwar J, Sulaiman A, Naumova NN, Anwar N. Correction: Amin et al. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025, 13, 207. Diseases. 2025; 13(8):257. https://doi.org/10.3390/diseases13080257

Chicago/Turabian Style

Amin, Nisar, Javaria Anwar, Abdullahi Sulaiman, Nadia Nikolaeva Naumova, and Nadeem Anwar. 2025. "Correction: Amin et al. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025, 13, 207" Diseases 13, no. 8: 257. https://doi.org/10.3390/diseases13080257

APA Style

Amin, N., Anwar, J., Sulaiman, A., Naumova, N. N., & Anwar, N. (2025). Correction: Amin et al. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025, 13, 207. Diseases, 13(8), 257. https://doi.org/10.3390/diseases13080257

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop